PDF file: 441-3068_and_PHAC_destruction_of_vials_new_vials_and_SV40.pdf
OPQ ID: 441-3068
Session: 441
Question number: Q-3068
Sessional paper: Q-3068
Title: and PHAC, destruction of vials, new vials and SV40
Short description: 
Topic: vaccines
Identified concern: 
Keywords: 
Agencies: HC, PHAC
Date asked: 2024-10-09
Date tabled: 
Submitted by: Mr. Carrie (Oshawa)
Reply by: Minister of Health
Responded by: Mr. Yasir Naqvi
Pages: 4
Status: not processed
Alert: yellow
Questions asked: 10
Questions answered: 3
Percent responded: 30%
Referenced sources: (none extracted)
Referenced links: (none extracted)
Official link: https://www.google.com/search?q=Q-3068+ourcommons.ca
PDF URL: https://ivim.ca/foi/opq/r/441-3068_and_PHAC_destruction_of_vials_new_vials_and_SV40.pdf
TXT URL: https://ivim.ca/foi/opq/r/441-3068.txt
Original filename: Q-3068_HC and PHAC, destruction of vials, new vials and SV40.pdf
Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2022\Q-3068_HC and PHAC, destruction of vials, new vials and SV40.pdf
Machine extracted at: 2026-06-30 12:58:28

References / links:
(none extracted)

Machine notes:
(none)

Question text preview:
With regard to Health Canada’s (HC) and the Public Health Agency of Canada’s (PHAC) decision to withdraw the market authorization and destruction of the COVID-19 XBB.1.5 vaccines and future assessment of upcoming mRNA vaccines: (a) are there material differences between the XBB.1.5 COVID-19 vaccines and the new 2024-2025 formulation beyond the mRNA coding for a different spike protein strain;
(b) if (a) is affirmative, what are the differences;
(c) if the answer to (a) is affirmative, how will Canadians processing claims against the vaccine manufacturers be able to prove their allegations when physical evidence is required and has been destroyed;
(d) what is the estimated number of COVID-19 vaccine vials that will be destroyed, broken down by manufacturer (Pfizer, Moderna, AstraZeneca, others);
(e) what is the estimated dollar cost to Canadians to destroy these vaccine products, per vaccine and in total;
(f) what is the regulatory process for COVID-19 vaccines which resulted in a “contractual obligation for Health Canada to withdraw all XBB products from the market until a lot could be released and distributed in Canada” (Global news);
(g) what is the contractual obligation in (f) and with whom;
(h) will provinces be able to order any interim supply of the COVID-19 XBB vaccines and, if not, why not;
(i) with respect to the statement made by
Pfizer/BioNTech on October 20, 2023, found on page 56 of Access to Information and Privacy (ATIP) 2024-000097-2024-08-22, that Pfizer
“would be open to discuss the outcome from the plasmid backbone modification evaluation with Health Canada”, does HC expect the removal of the SV40 sequences from the updated Pfizer/BioNTech COVID-19 vaccines for 2024-25;
(j) is HC considering the assessment of future mRNA-based vaccines to continue under the Centre for Vaccines, Clinical Trials and Biostatistics or to be transferred to another
Centre or Department within Biologic and Radiopharmaceutical Drugs Directorate or elsewhere; and, if so, what would be the criteria or rationale?